These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10573322)

  • 1. Is valproate pharmacotherapy associated with polycystic ovaries?
    Chappell KA; Markowitz JS; Jackson CW
    Ann Pharmacother; 1999 Nov; 33(11):1211-6. PubMed ID: 10573322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases.
    Isojarvi JI; Tapanainen JS
    Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate treatment and the risk of hyperandrogenism and polycystic ovaries.
    Soares JC
    Bipolar Disord; 2000 Mar; 2(1):37-41. PubMed ID: 11254018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
    N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ovarian function and cardiovascular risk factors in valproate-treated women.
    Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS
    Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X; Wang J; Dong W; Fang Q; Hu L; Liu C
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VALPROATE, BIPOLAR DISORDER AND POLYCYSTIC OVARIAN SYNDROME.
    Okanović M; Zivanović O
    Med Pregl; 2016; 69(3-4):121-6. PubMed ID: 27506102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the association between valproate and polycystic ovary syndrome.
    Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV
    Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of valproate on sexual development].
    Balaguer Martínez JV; López García MJ; Andrés Celma M; Contell Villagrasa A; Castelló Pomares ML
    An Pediatr (Barc); 2003 May; 58(5):443-8. PubMed ID: 12724077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.
    Löfgren E; Mikkonen K; Tolonen U; Pakarinen A; Koivunen R; Myllyla VV; Tapanainen JS; Isojärvi JI
    Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats.
    Taubøll E; Isojärvi JI; Harbo HF; Pakarinen AJ; Gjerstad L
    Seizure; 1999 Dec; 8(8):490-3. PubMed ID: 10627413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.
    O'Donovan C; Kusumakar V; Graves GR; Bird DC
    J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More on valproate and polycystic ovaries.
    Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of ovulatory failure in women with epilepsy.
    Morrell MJ; Giudice L; Flynn KL; Seale CG; Paulson AJ; Doñe S; Flaster E; Ferin M; Sauer MV
    Ann Neurol; 2002 Dec; 52(6):704-11. PubMed ID: 12447923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The dangers of valproate in women].
    Isojärvi J
    Duodecim; 1998; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.